Stanislav Glezer
Chief Tech/Sci/R&D Officer presso INOGEN, INC.
Patrimonio netto: 129 975 $ in data 31/03/2024
Posizioni attive di Stanislav Glezer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INOGEN, INC. | Chief Tech/Sci/R&D Officer | 21/06/2021 | - |
| Diabetes Foundation of New Jersey | Director/Board Member | 24/07/2019 | - |
Storia della carriera di Stanislav Glezer
Precedenti posizioni note di Stanislav Glezer
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BECTON, DICKINSON AND COMPANY | Chief Tech/Sci/R&D Officer | 01/09/2018 | 01/06/2021 |
| ADOCIA | Chief Tech/Sci/R&D Officer | 26/07/2017 | 01/05/2018 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Chief Tech/Sci/R&D Officer | 01/03/2016 | 01/03/2017 |
| Sanofi SA | Corporate Officer/Principal | - | - |
Formazione di Stanislav Glezer
| California Coast University | Masters Business Admin |
| Yevdokimov MSUMD | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Francia | 3 |
| Russia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| INOGEN, INC. | Health Technology |
| ADOCIA | Health Technology |
| Aziende private | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Sanofi SA | Health Technology |
| Diabetes Foundation of New Jersey |
- Borsa valori
- Insiders
- Stanislav Glezer
- Esperienza
